• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭患者的经皮腔内肾血管成形术

Percutaneous transluminal renal angioplasty in patients with renal failure.

作者信息

Pattison J M, Reidy J F, Rafferty M J, Ogg C S, Cameron J S, Sacks S H, Williams D G

机构信息

Department of Renal Medicine, Guy's Hospital, London.

出版信息

Q J Med. 1992 Nov-Dec;85(307-308):883-8.

PMID:1484950
Abstract

Renovascular disease is a common cause of end-stage renal failure in the elderly population. We assessed the role of percutaneous transluminal renal angioplasty in the treatment of patients with renal failure due to renovascular disease by analysing our results in 60 patients treated between 1982 and 1991. All the patients had a baseline serum creatinine level greater than 150 mumol/l; improvement in renal function was defined as a 20 per cent reduction in this level. Seventy-five angioplasty procedures were attempted on 70 arteries in 60 patients. There was an improvement in renal function in 24 patients (40 per cent), whilst six (10 per cent) showed deterioration. The most dramatic improvement was seen in a small group of patients who had suffered an acute deterioration in renal function prior to angioplasty. There was a low incidence of serious complications. Renovascular disease is an important reversible cause of chronic renal failure and should be investigated aggressively so that percutaneous transluminal renal angioplasty can be undertaken in selected patients.

摘要

肾血管疾病是老年人群终末期肾衰竭的常见病因。我们通过分析1982年至1991年间接受治疗的60例患者的结果,评估了经皮腔内肾血管成形术在治疗因肾血管疾病导致肾衰竭患者中的作用。所有患者的基线血清肌酐水平均高于150μmol/L;肾功能改善定义为该水平降低20%。对60例患者的70条动脉进行了75次血管成形术尝试。24例患者(40%)肾功能得到改善,而6例(10%)出现恶化。在血管成形术前肾功能急性恶化的一小部分患者中观察到了最显著的改善。严重并发症的发生率较低。肾血管疾病是慢性肾衰竭的一个重要可逆病因,应积极进行检查,以便在选定的患者中开展经皮腔内肾血管成形术。

相似文献

1
Percutaneous transluminal renal angioplasty in patients with renal failure.肾衰竭患者的经皮腔内肾血管成形术
Q J Med. 1992 Nov-Dec;85(307-308):883-8.
2
Percutaneous transluminal angioplasty for atheromatous renal artery stenosis--blood pressure response and discriminant analysis of outcome predictors.经皮腔内血管成形术治疗动脉粥样硬化性肾动脉狭窄——血压反应及结局预测因素的判别分析
Q J Med. 1990 May;75(277):483-9.
3
Comparison of early and long-term impact of percutaneous transluminal renal artery angioplasty alone or with brachytherapy on renal function in patients with reno-vascular hypertension.经皮腔内肾动脉血管成形术单独或联合近距离放射治疗对肾血管性高血压患者肾功能的早期和长期影响比较
Kardiol Pol. 2008 Oct;66(10):1061-6; discussion 1067-8.
4
Renovascular hypertension: the small kidney updated.肾血管性高血压:小肾脏的新进展
Q J Med. 1988 Mar;66(251):203-17.
5
[Pattern of blood creatinine levels in 140 hypertensive patients after successful percutaneous transluminal angioplasty for renal artery stenosis].[140例肾动脉狭窄患者经皮腔内血管成形术成功后血肌酐水平变化模式]
J Radiol. 1993 Dec;74(12):609-13.
6
[The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis].经皮腔内肾动脉狭窄扩张术后动脉血压及肾功能的长期结果
Med Clin (Barc). 1997 Mar 15;108(10):366-72.
7
Captopril therapy following percutaneous transluminal angioplasty for bilateral renal artery stenosis.经皮腔内血管成形术治疗双侧肾动脉狭窄后的卡托普利治疗
Arch Intern Med. 1989 Sep;149(9):1973-6.
8
Percutaneous transluminal renal angioplasty in the management of hypertension and renal failure in patients with renal artery stenosis.经皮腔内肾血管成形术治疗肾动脉狭窄患者的高血压和肾衰竭
J Hum Hypertens. 1993 Oct;7(5):491-6.
9
Percutaneous transluminal angioplasty improves blood pressure and renal function in renovascular hypertension.经皮腔内血管成形术可改善肾血管性高血压患者的血压和肾功能。
Q J Med. 1987 May;63(241):393-403.
10
[Ischemic renal disease: revascularization or conservative treatment?].缺血性肾病:血管重建术还是保守治疗?
Nefrologia. 2005;25(3):258-68.

引用本文的文献

1
Renovascular disease: the fifth frontier.肾血管疾病:第五个前沿领域。
J R Soc Med. 1997 Jun;90(6):315-8. doi: 10.1177/014107689709000606.